Skip to content
The Policy VaultThe Policy Vault

Ibrance (palbociclib capsules and tablets) — Cigna

Liposarcoma

Initial criteria

  • Patient is age ≥ 18 years
  • Patient has well-differentiated/dedifferentiated liposarcoma

Approval duration

1 year